Phase I study of weekly oxaliplatin plus irinotecan in previously treated patients with metastatic colorectal cancer Academic Article uri icon

Overview

MeSH Major

  • Acquired Immunodeficiency Syndrome

abstract

  • Weekly combination of oxaliplatin and irinotecan appears to be a well tolerated and active regimen in patients previously treated for metastatic colorectal cancer. Further investigations of this regimen are warranted.

publication date

  • September 2002

Research

keywords

  • Academic Article

Identity

Digital Object Identifier (DOI)

  • 10.1093/annonc/mdf247

Additional Document Info

start page

  • 1490

end page

  • 6

volume

  • 13

number

  • 9